Details
Stereochemistry | RACEMIC |
Molecular Formula | C11H11I3NO2.Na |
Molecular Weight | 592.9137 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].CCC(CC1=C(I)C(N)=C(I)C=C1I)C([O-])=O
InChI
InChIKey=LEXZDSSHLHPSQC-UHFFFAOYSA-M
InChI=1S/C11H12I3NO2.Na/c1-2-5(11(16)17)3-6-7(12)4-8(13)10(15)9(6)14;/h4-5H,2-3,15H2,1H3,(H,16,17);/q;+1/p-1
Molecular Formula | C11H11I3NO2 |
Molecular Weight | 569.924 |
Charge | -1 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Molecular Formula | Na |
Molecular Weight | 22.9898 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Originator
Sources: http://www.springer.com/kr/book/9783642695179
Curator's Comment: M. Sovak. Radiocontrast Agents. (1984), p. 383. ISBN13: 9783642695179
Approval Year
Doses
Dose | Population | Adverse events |
---|---|---|
75 g single, oral Overdose |
unknown, 42 years n = 1 Health Status: unknown Condition: used for diagnosis Age Group: 42 years Sex: M Population Size: 1 Sources: |
Disc. AE: Diarrhea... AEs leading to discontinuation/dose reduction: Diarrhea (1 patient) Sources: |
3 g single, oral Recommended |
unknown, adult n = 48 Health Status: unknown Condition: used for diagnosis Age Group: adult Sex: unknown Population Size: 48 Sources: |
Other AEs: Gastrointestinal disorders... |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Diarrhea | 1 patient Disc. AE |
75 g single, oral Overdose |
unknown, 42 years n = 1 Health Status: unknown Condition: used for diagnosis Age Group: 42 years Sex: M Population Size: 1 Sources: |
Gastrointestinal disorders | 39 patients | 3 g single, oral Recommended |
unknown, adult n = 48 Health Status: unknown Condition: used for diagnosis Age Group: adult Sex: unknown Population Size: 48 Sources: |
PubMed
Title | Date | PubMed |
---|---|---|
Additive nephrotoxicity from roentgenographic contrast media. Its occurrence in phenazopyridine-induced acute renal failure. | 1981 May |
|
A test of the hypothesis that T3 is the "seasonality" thyroid hormone in American tree sparrows (Spizella arborea): intracerebroventricular infusion of iopanoic acid, an inhibitor of T3 synthesis and degradation. | 2001 Mar |
|
A surface-modified chylomicron remnant-like emulsion for percutaneous computed tomography lymphography: synthesis and preliminary imaging findings. | 2002 Apr |
|
Perioperative management of the thyrotoxic patient. | 2003 Jun |
|
Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study. | 2003 May |
|
Is there a place for thyroidectomy in older patients with thyrotoxic storm and cardiorespiratory failure? | 2003 Oct |
|
Inhibition of drug binding to human serum albumin by cholecystographic agents. | 2003 Sep |
|
Thyroid hormones interact with glucocorticoids to affect somatotroph abundance in chicken embryonic pituitary cells in vitro. | 2003 Sep |
|
Treatment of hyperthyroidism associated with thyrotropin-secreting pituitary adenomas with iopanoic acid. | 2004 Feb |
|
Iopanoic acid in the management of neonatal Graves' disease. | 2004 Feb |
|
Expression of type II iodothyronine deiodinase marks the time that a tissue responds to thyroid hormone-induced metamorphosis in Xenopus laevis. | 2004 Feb 1 |
|
Oral contrast-enhanced CT cholangiography--an initial experience. | 2004 Jan |
|
Percutaneous transcholecystic biliary interventions using gallbladder anchors: feasibility study in the swine. | 2005 Jul-Aug |
|
Unliganded thyroid hormone receptor is essential for Xenopus laevis eye development. | 2006 Oct 18 |
|
An in vivo multiwell-based fluorescent screen for monitoring vertebrate thyroid hormone disruption. | 2007 Aug 15 |
|
A fatal case of recurrent amiodarone-induced thyrotoxicosis after percutaneous tracheotomy: a case report. | 2007 Nov 13 |
|
Pharmacodynamic effect of iopanoic acid on free T(3) and T(4) levels in amiodarone-induced thyrotoxicosis. | 2008 Dec |
|
[Rapid preoperative preparation with iopanoic acid in severe liver toxicity due to methimazole: anesthetic implications]. | 2008 Feb |
|
Morphological and biochemical changes in the Harderian gland of hypothyroid rats. | 2008 Feb |
|
Structural basis of GC-1 selectivity for thyroid hormone receptor isoforms. | 2008 Jan 31 |
|
Vaccination of feral pigs (Sus scrofa) using iophenoxic acid as a simulated vaccine. | 2008 Jan-Feb |
|
Amiodarone-induced thyrotoxicosis. A review. | 2008 Sep |
|
Competitive inhibition of organic anion transporting polypeptide 1c1-mediated thyroxine transport by the fenamate class of nonsteroidal antiinflammatory drugs. | 2009 Feb |
|
Anesthetic considerations in a patient with amiodarone-induced thyrotoxicosis. | 2010 |
|
Analysis by LC/ESI-MS of iophenoxic acid derivatives and evaluation as markers of oral baits to deliver pharmaceuticals to wildlife. | 2010 Jul 15 |
|
Monitoring of deiodinase deficiency based on transcriptomic responses in SH-SY5Y cells. | 2013 Jun |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1304283
Take 500 mg orally twice a day for the first 3 weeks.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:04:20 GMT 2023
by
admin
on
Sat Dec 16 10:04:20 GMT 2023
|
Record UNII |
439WET4G58
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
219-683-3
Created by
admin on Sat Dec 16 10:04:20 GMT 2023 , Edited by admin on Sat Dec 16 10:04:20 GMT 2023
|
PRIMARY | |||
|
m6371
Created by
admin on Sat Dec 16 10:04:20 GMT 2023 , Edited by admin on Sat Dec 16 10:04:20 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB02750MIG
Created by
admin on Sat Dec 16 10:04:20 GMT 2023 , Edited by admin on Sat Dec 16 10:04:20 GMT 2023
|
PRIMARY | |||
|
439WET4G58
Created by
admin on Sat Dec 16 10:04:20 GMT 2023 , Edited by admin on Sat Dec 16 10:04:20 GMT 2023
|
PRIMARY | |||
|
23669441
Created by
admin on Sat Dec 16 10:04:20 GMT 2023 , Edited by admin on Sat Dec 16 10:04:20 GMT 2023
|
PRIMARY | |||
|
340398
Created by
admin on Sat Dec 16 10:04:20 GMT 2023 , Edited by admin on Sat Dec 16 10:04:20 GMT 2023
|
PRIMARY | RxNorm | ||
|
DTXSID20947842
Created by
admin on Sat Dec 16 10:04:20 GMT 2023 , Edited by admin on Sat Dec 16 10:04:20 GMT 2023
|
PRIMARY | |||
|
100000086410
Created by
admin on Sat Dec 16 10:04:20 GMT 2023 , Edited by admin on Sat Dec 16 10:04:20 GMT 2023
|
PRIMARY | |||
|
138711-85-0
Created by
admin on Sat Dec 16 10:04:20 GMT 2023 , Edited by admin on Sat Dec 16 10:04:20 GMT 2023
|
SUPERSEDED | |||
|
2497-78-1
Created by
admin on Sat Dec 16 10:04:20 GMT 2023 , Edited by admin on Sat Dec 16 10:04:20 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |